Kroetz uses pharmacogenetics to determine the best treatment options for leukemia patients

Some leukemia cells supercharge cell pumps to get rid of chemotherapy. UCSF School of Pharmacy faculty member and pharmacogenetics researcher Deanna Kroetz, PhD, is aiming toward a simple way to identify these tumors, select the best treatment and avoid complications.

Full story

[Leukemia Survival and Pharmacogenetics][link defunct as of April 1, 2013]

Tags

Category:
Sites:
School of Pharmacy, Department of Bioengineering and Therapeutic Sciences, PharmD Degree Program, QBC, PSPG

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.